Use of Proceeds
On June 18, 2021, we consummated our Public Offering of 34,500,000 Units, including 4,500,000 Over-allotment Units. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $345,000,000.
Simultaneously with the consummation of the Public Offering, we completed the private sale of 10,550,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $10,550,000.
Citigroup Global Markets Inc. and Barclays Capital Inc. served as underwriters for the Public Offering. The securities sold in the Public Offering were registered under the Securities Act on a registration statement on Form S-1 (File No. 333-254940) (the “Registration Statement”). The SEC declared the Registration Statement effective on June 15, 2021.
From February 25, 2021 (inception) through December 31, 2021, we incurred $1,376,851 for costs and expenses related to the Public Offering. In connection with the closing of the Public Offering, we paid a total of $6,200,000 in underwriting discounts and commissions. In addition, the underwriters agreed to defer $10,850,000 in underwriting discounts and commissions, which amount will be payable upon consummation of the initial business combination. Prior to the closing of the Public Offering, the Sponsor loaned us $300,000 under the Note. We repaid this Note to our Sponsor on June 21, 2021. There has been no material change in the planned use of proceeds from the Public Offering as described in our final prospectus filed with the SEC on June 17, 2021.
After deducting the underwriting discounts and commissions (excluding the deferred portion of $10,850,000, which amount will be payable upon consummation of our initial business combination) and offering expenses, the total net proceeds from the Public Offering and the sale of the Private Placement Warrants were $355,550,000, of which $345,000,000 (or $10.00 per share sold in the Public Offering) was placed in the Trust Account.
There has been no material change in the planned use of the proceeds from the Public Offering and Private Placement as is described in the Company’s final prospectus related to the Public Offering. For a description of the use of the proceeds generated from the Public Offering, see “Item 1. Business.”
Item 6. [Reserved.]
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the audited financial statements and the notes related thereto which are included in “Part II, Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Cautionary Note Regarding Forward-Looking Statements,” “Part I, Item 1A. Risk Factors” and elsewhere in this Annual Report on Form 10-K.
Overview
We are a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our Sponsor is an affiliate of a private investment fund management by Zimmer, a Delaware limited partnership that manages several investment vehicles. Although we may pursue an acquisition opportunity in any business or industry, we intend to capitalize on the Zimmer platform to identify, acquire and operate a business in industries that may provide opportunities for attractive risk-adjusted returns in the energy value chain in North America, with a focus on energy transition and sustainability. This broadly includes environmental, social and governance growth-focused companies in the energy, industrial, and infrastructure sectors.
The Registration Statement for our Public Offering was declared effective on June 15, 2021. On June 18, 2021, we consummated our Public Offering of 34,500,000 Units, which includes the exercise in full of the underwriters’ option to purchase an additional 4,500,000 Units, at a price of $10.00 per Unit, generating gross proceeds to us of $345,000,000. Transaction costs for the Public Offering amounted to $18,426,851, consisting of $6,200,000 of underwriting discounts and commissions, $10,850,000 of deferred underwriting discounts and commissions, and $1,376,851 of other offering costs.